Several studies have demonstrated that miRNA-mediated targeting of MTA1 resulted in repression of EMT leading to diminished invasion and migration of human pancreatic, gastric, and non- small cell lung cancer (62–64). This evidence concerns the gene MTA1 and non-small cell lung carcinoma.